BARCLAYS PLC - ENLIVEX THERAPEUTICS LTD ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ENLIVEX THERAPEUTICS LTD
ValueSharesWeighting
Q3 2023$2
-33.3%
1,0000.0%0.00%
Q2 2023$3
-25.0%
1,0000.0%0.00%
Q1 2023$40.0%1,0000.0%0.00%
Q4 2022$4
-99.9%
1,0000.0%0.00%
Q3 2022$4,000
-20.0%
1,0000.0%0.00%
Q2 2022$5,000
-16.7%
1,0000.0%0.00%
Q1 2022$6,0001,0000.00%
Other shareholders
ENLIVEX THERAPEUTICS LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Golden Green, Inc. 69,782$774,0000.67%
ARK Investment Management 476,414$5,283,0000.01%
Compagnie Lombard Odier SCmA 25,000$267,0000.01%
EDMOND DE ROTHSCHILD HOLDING S.A. 13,000$144,0000.00%
Renaissance Technologies 290,406$3,221,0000.00%
Steward Partners Investment Advisory, LLC 31,000$330,758,0000.00%
MARSHALL WACE, LLP 33,889$376,0000.00%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 700$6,0000.00%
SOA Wealth Advisors, LLC. 327$3,0000.00%
BANK OF AMERICA CORP /DE/ 3,135$35,0000.00%
View complete list of ENLIVEX THERAPEUTICS LTD shareholders